The efficacy and safety of reduced-dose docetaxel, cisplatin, and 5-fluorouracil in the first-line treatment of advanced stage gastric adenocarcinoma

Medical Oncology

Volumn 27, Issue 3, 2010, Pages 680-684

  Özdemir, Nuriye Yildirim ^a   AbalI, Hüseyin ^b   Öksüzoǧlu, Berna ^a   Budakoglu, Burçin ^a   Uncu, Doǧan ^a   Güler, Tunç ^a   OdabaşI, Hatice ^a   Zengin, Nurullah ^a  

^a MINISTRY OF HEALTH   (Turkey)

^b BASKENT UNIVERSITY   (Turkey)

Author keywords

Advanced gastric cancer; Cisplatin; Docetaxel; Fluorouracil; Modified

Indexed keywords

CISPLATIN; DOCETAXEL; FLUOROURACIL;

ADULT; ADVANCED CANCER; ANEMIA; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER STAGING; CLINICAL ARTICLE; CLINICAL PROTOCOL; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG FATALITY; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; FEMALE; HUMAN; MALE; MULTIPLE CYCLE TREATMENT; NAUSEA; NEUTROPENIA; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; STOMACH ADENOCARCINOMA; STOMACH CARCINOMA; THROMBOCYTOPENIA; TREATMENT RESPONSE; VOMITING;

ADENOCARCINOMA; ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CAMPTOTHECIN; CISPLATIN; DISEASE-FREE SURVIVAL; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FEVER; FLUOROURACIL; FOLLOW-UP STUDIES; GASTROINTESTINAL DISEASES; GRANULOCYTE COLONY-STIMULATING FACTOR; HEMATOLOGIC DISEASES; HUMANS; KAPLAN-MEIER ESTIMATE; LEUCOVORIN; MALE; MIDDLE AGED; NEUTROPENIA; RETROSPECTIVE STUDIES; STOMACH NEOPLASMS; TAXOIDS; YOUNG ADULT;

EID: 77956920955     PISSN: 13570560     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12032-009-9268-y     Document Type: Article

References (19)

1. F Kamangar GM Dores WF Anderson 2006 Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world J Clin Oncol 24 2137 2150 10.1200/JCO.2005.05.2308 16682732 (Pubitemid 46655601)
2. CS Fuchs RJ Mayer 1995 Gastric carcinoma N Engl J Med 333 32 41 10.1056/NEJM199507063330107 1:STN:280:DyaK2M3psFOmuw%3D%3D 7776992
3. S Pyrhonen T Kuitunen P Nyandoto M Kouri 1995 Randomised comparison of fluorouracil, epidoxorubicin and methotrexate (FEMTX) plus supportive care with supportive care alone in patients with non-resectable gastric cancer Br J Cancer 71 587 591 1:STN:280:DyaK2M7os1ertg%3D%3D 7533517
4. AM Murad, et al. 1993 Modified therapy with 5-fluorouracil, doxorubicin, and methotrexate in advanced gastric cancer Cancer 72 37 41 10.1002/1097- 0142(19930701)72:1<37::AID-CNCR2820720109>3.0.CO;2-P 1:STN:280: DyaK3s3osVGqtQ%3D%3D 8508427
5. B Glimelius, et al. 1997 Randomized comparison between chemotherapy plus best supportive care with best supportive care in advanced gastric cancer Ann Oncol 8 163 168 10.1023/A:1008243606668 1:STN:280:DyaK2s3kslGqug%3D%3D 9093725 (Pubitemid 27112884)
6. AD Wagner, et al. 2006 Chemotherapy in advanced gastric cancer: a systematic review and meta-analysis based on aggregate data J Clin Oncol 24 2903 2909 10.1200/JCO.2005.05.0245 1:CAS:528:DC%2BD28XntV2gs7s%3D 16782930 (Pubitemid 46630593)
7. P Preusser, et al. 1989 Phase II study with the combination etoposide, doxorubicin, and cisplatin in advanced measurable gastric cancer J Clin Oncol 7 1310 1317 1:STN:280:DyaL1MzmtFGltA%3D%3D 2671287
8. A Lerner R Gonin GD Steele RJ Mayer 1992 Etoposide, doxorubicin, and cisplatin chemotherapy for advanced gastric adenocarcinoma: results of a phase II trial J Clin Oncol 10 536 540 1:STN:280:DyaK387ptl2lsg%3D%3D 1548518
9. A Webb, et al. 1997 Randomized trial comparing epirubicin, cisplatin, and fluorouracil versus fluorouracil, doxorubicin, and methotrexate in advanced esophagogastric cancer J Clin Oncol 15 261 267 1:CAS:528:DyaK2sXnsV2msA%3D%3D 8996151
10. CH Kohne, et al. 2003 Randomized phase III study of high-dose fluorouracil given as a weekly 24-hour infusion with or without leucovorin versus bolus fluorouracil plus leucovorin in advanced colorectal cancer: European organization of Research and Treatment of Cancer Gastrointestinal Group Study 40952 J Clin Oncol 21 3721 3728 10.1200/JCO.2003.11.122 12963704 (Pubitemid 46606225)
11. A Ohtsu, et al. 2003 Randomized phase III trial of fluorouracil alone versus fluorouracil plus cisplatin versus uracil and tegafur plus mitomycin in patients with unresectable, advanced gastric cancer: The Japan Clinical Oncology Group Study (JCOG9205) J Clin Oncol 21 54 59 10.1200/JCO.2003.04.130 1:CAS:528:DC%2BD2cXpsVWru7k%3D 12506170
12. SA Cullinan, et al. 1985 A comparison of three chemotherapeutic regimens in the treatment of advanced pancreatic and gastric carcinoma. Fluorouracil vs. fluorouracil and doxorubicin vs. fluorouracil, doxorubicin, and mitomycin JAMA 253 2061 2067 10.1001/jama.253.14.2061 1:STN:280:DyaL2M7jsFalsw%3D%3D 2579257 (Pubitemid 15102220)
13. W Koizumi, et al. 2008 S-1 plus cisplatin versus S-1 alone for first-line treatment of advanced gastric cancer (SPIRITS trial): a phase III trial Lancet Oncol 9 215 221 10.1016/S1470-2045(08)70035-4 1:CAS:528:DC%2BD1cXivVaqtb4%3D 18282805
14. U Vanhoefer, et al. 2000 Final results of a randomized phase III trial of sequential high-dose methotrexate, fluorouracil, and doxorubicin versus etoposide, leucovorin, and fluorouracil versus infusional fluorouracil and cisplatin in advanced gastric cancer: A trial of the European Organization for Research and Treatment of Cancer Gastrointestinal Tract Cancer Cooperative Group J Clin Oncol 18 2648 2657 1:CAS:528:DC%2BD3cXls12iurk%3D 10894863
15. K Muro, et al. 2004 A phase II study of single-agent docetaxel in patients with metastatic esophageal cancer Ann Oncol 15 955 959 10.1093/annonc/mdh231 1:STN:280:DC%2BD2c3lt12jtA%3D%3D 15151954 (Pubitemid 39004353)
16. JA Ajani, et al. 2002 CPT-11 plus cisplatin in patients with advanced, untreated gastric or gastroesophageal junction carcinoma: results of a phase II study Cancer 94 641 646 10.1002/cncr.10279 1:CAS:528:DC%2BD38XhsVOjtbc%3D 11857295 (Pubitemid 34132291)
17. A Ohtsu, et al. 1998 An early phase II study of a 3-hour infusion of paclitaxel for advanced gastric cancer Am J Clin Oncol 21 416 419 10.1097/00000421-199808000-00021 1:STN:280:DyaK1cznt1emsw%3D%3D 9708646 (Pubitemid 28366916)
18. E Van Cutsem, et al. 2006 Phase III study of docetaxel and cisplatin plus fluorouracil compared with cisplatin and fluorouracil as first-line therapy for advanced gastric cancer: a report of the V325 Study Group J Clin Oncol 24 4991 4997 10.1200/JCO.2006.06.8429 17075117 (Pubitemid 46631401)
19. AD Roth, et al. 2007 Docetaxel, cisplatin, and fluorouracil; docetaxel and cisplatin; and epirubicin, cisplatin, and fluorouracil as systemic treatment for advanced gastric carcinoma: a randomized phase II trial of the Swiss Group for Clinical Cancer Research J Clin Oncol 25 3217 3223 10.1200/JCO.2006.08.0135 1:CAS:528:DC%2BD2sXhtVWqs7rP 17664469 (Pubitemid 47325604)